MYCN and neuroblastoma: Furthermore, MYCN amplification reprogrammes metabolism in neuroblastoma in several ways, including effects to pathways targeted by indisulam by both RBM39-dependent and independent means, such as glutaminolysis38,39, lipogenesis, the serine-glycine synthesis and one-carbon metabolic pathway40 and reactive oxygen species production38.